# Voyageur Pharmaceuticals Ltd. (VYYRF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VYYRF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 19.3K | $ -627.4K | $ -165.1K | $ 40.0K | $ 660.7K |
| 2025 | $ 11.7K | $ -3.23M | $ -3.01M | $ 40.0K | $ 1.25M |
| 2024 | $ 0 | $ -1.74M | $ -385.1K | $ 40.0K | $ 450.0K |
| 2023 | $ 0 | $ -1.46M | $ -1.21M | $ 40.0K | $ 1.44M |
| 2022 | $ 0 | $ -1.85M | $ -1.94M | $ 25.5K | $ 1.46M |
| 2021 | $ 0 | $ -1.48M | $ -2.38M | $ 42.1K | $ 1.91M |
| 2020 | $ 0 | $ -1.33M | $ -353.4K | $ 268.4K | $ 306.3K |
| 2019 | $ 0 | $ -665.1K | $ -770.3K | $ 138.6K | $ 754.1K |
| 2018 | $ 0 | $ -684.4K | $ -1.34M | $ 179.6K | $ 515.7K |
| 2017 | $ 0 | $ -842.3K | $ -1.45M | $ 49.9K | $ -89.2K |
| 2016 | $ 0 | $ -66.9K | $ -45.1K | $ 0 | $ 670.5K |
| 2015 | $ 0 | $ 25.5K | $ -91.7K | $ 0 | $ 80.1K |
| 2014 | $ 0 | $ -124.6K | $ -31.2K | $ 0 | $ 81.6K |
| 2013 | $ 0 | $ -60.7K | $ -73.3K | $ 0 | $ 176.0K |
| 2012 | $ 0 | $ -115.9K | $ 3.1K | $ 0 | $ 221.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.06 |
| Liabilities / Eq | 3.46 |
| Current Ratio | 0.18 |

## Other views

- [Metrics](https://sponda.capital/en/VYYRF.md)
- [Charts](https://sponda.capital/en/VYYRF/charts.md)
- [Compare](https://sponda.capital/en/VYYRF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.